Radiotherapy developer Eckert & Ziegler Bebig has received Chinese State Food and Drug Administration (SFDA) clearance for its MultiSource high-dose-rate (HDR) afterloading system for brachytherapy.
MultiSource is an afterloader that is designed for the entire range of HDR brachytherapy applications, according to the firm. Customers can choose between either an iridium-192 source or a cobalt-60 source with a half-life of 5.26 years, the company said. An in vivo dosimetry system is also included.
